Clinical trial
FEMaLe: The Use of Machine Learning for Early Diagnosis of Endometriosis Based on Patient Self-reported Data - Study Protocol of a Multicenter Trial
NCT06147687 is registered in ClinicalTrials.gov with Semmelweis University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- FEMaLe: The Use of Machine Learning for Early Diagnosis of Endometriosis Based on Patient Self-reported Data - Study Protocol of a Multicenter Trial
- Lead sponsor
- Semmelweis University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 1, 2022
- Completion date
- December 31, 2024
- Enrollment
- 10,000 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.